EverolimuS-Eluting Bioresorbable VasCular ScaffOlds Versus EveRolimus-Eluting Stents in Patients With Chronic Total Occlusion
Phase of Trial: Phase IV
Latest Information Update: 18 Apr 2017
At a glance
- Drugs Everolimus (Primary)
- Indications Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms SCORE-CTO
- 12 Apr 2017 Status changed from recruiting to discontinued.
- 21 Sep 2016 Status changed from not yet recruiting to recruiting.
- 20 Apr 2016 New trial record